Novo Nordisk had a revenue of 85.68B in the quarter ending Dec 31, 2024, with 20.15%. This bring the company's revenue in the last twelve months to 290.40B, Decreased 7.32%. In the fiscal year ending Dec 31, 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.